Skip to main content
Top
Published in: Diabetologia 4/2016

Open Access 01-04-2016 | Article

Associations of total amount and patterns of sedentary behaviour with type 2 diabetes and the metabolic syndrome: The Maastricht Study

Authors: Julianne D. van der Berg, Coen D. A. Stehouwer, Hans Bosma, Jeroen H. P. M. van der Velde, Paul J. B. Willems, Hans H. C. M. Savelberg, Miranda T. Schram, Simone J. S. Sep, Carla J. H. van der Kallen, Ronald M. A. Henry, Pieter C. Dagnelie, Nicolaas C. Schaper, Annemarie Koster

Published in: Diabetologia | Issue 4/2016

Login to get access

Abstract

Aims/hypothesis

The study investigated cross-sectional associations of total amount and patterns of sedentary behaviour with glucose metabolism status and the metabolic syndrome.

Methods

We included 2,497 participants (mean age 60.0 ± 8.1 years, 52% men) from The Maastricht Study who were asked to wear an activPAL accelerometer 24 h/day for 8 consecutive days. We calculated the daily amount of sedentary time, daily number of sedentary breaks and prolonged sedentary bouts (≥30 min), and the average duration of the sedentary bouts. To determine glucose metabolism status, participants underwent an oral glucose tolerance test. Associations of sedentary behaviour variables with glucose metabolism status and the metabolic syndrome were examined using multinomial logistic regression analyses.

Results

Overall, 1,395 (55.9%) participants had normal glucose metabolism, 388 (15.5%) had impaired glucose metabolism and 714 (28.6%) had type 2 diabetes. The odds ratio per additional hour of sedentary time was 1.22 (95% CI 1.13, 1.32) for type 2 diabetes and 1.39 (1.27, 1.53) for the metabolic syndrome. No significant or only weak associations were seen for the number of sedentary breaks, number of prolonged sedentary bouts or average bout duration with either glucose metabolism status or the metabolic syndrome.

Conclusions/interpretation

An extra hour of sedentary time was associated with a 22% increased odds for type 2 diabetes and a 39% increased odds for the metabolic syndrome. The pattern in which sedentary time was accumulated was weakly associated with the presence of the metabolic syndrome. These results suggest that sedentary behaviour may play a significant role in the development and prevention of type 2 diabetes, although longitudinal studies are needed to confirm our findings.
Literature
1.
go back to reference Wild S, Roglic G, Green A et al (2004) Estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053CrossRefPubMed Wild S, Roglic G, Green A et al (2004) Estimates for the year 2000 and projections for 2030. Diabetes Care 27:1047–1053CrossRefPubMed
2.
go back to reference American Diabetes Association (2014) Standards of medical care in diabetes-2014. Diabetes Care 37(Suppl 1):S14–S80CrossRef American Diabetes Association (2014) Standards of medical care in diabetes-2014. Diabetes Care 37(Suppl 1):S14–S80CrossRef
3.
go back to reference International Diabetes Federation (2012) Global guideline for type 2 diabetes. International Diabetes Federation, Brussels International Diabetes Federation (2012) Global guideline for type 2 diabetes. International Diabetes Federation, Brussels
4.
go back to reference Sedentary Behaviour Research Network (2012) Standardized use of the terms “sedentary” and “sedentary behaviours”. Appl Physiol Nutr Metab 37:540–542CrossRefPubMed Sedentary Behaviour Research Network (2012) Standardized use of the terms “sedentary” and “sedentary behaviours”. Appl Physiol Nutr Metab 37:540–542CrossRefPubMed
5.
go back to reference Cooper AR, Sebire S, Montgomery AA et al (2012) Sedentary time, breaks in sedentary time and metabolic variables in people with newly diagnosed type 2 diabetes. Diabetologia 55:589–599CrossRefPubMed Cooper AR, Sebire S, Montgomery AA et al (2012) Sedentary time, breaks in sedentary time and metabolic variables in people with newly diagnosed type 2 diabetes. Diabetologia 55:589–599CrossRefPubMed
6.
7.
go back to reference Healy GN, Winkler EAH, Brakenridge CL et al (2015) Accelerometer-derived sedentary and physical activity time in overweight/obese adults with type 2 diabetes: cross-sectional associations with cardiometabolic biomarkers. PLoS One 10:e0119140CrossRefPubMedPubMedCentral Healy GN, Winkler EAH, Brakenridge CL et al (2015) Accelerometer-derived sedentary and physical activity time in overweight/obese adults with type 2 diabetes: cross-sectional associations with cardiometabolic biomarkers. PLoS One 10:e0119140CrossRefPubMedPubMedCentral
8.
go back to reference Healy G, Wijndaele K, Dunstan D et al (2008) Objectively measured sedentary time, physical activity, and metabolic risk. Diabetes Care 31:369–371CrossRefPubMed Healy G, Wijndaele K, Dunstan D et al (2008) Objectively measured sedentary time, physical activity, and metabolic risk. Diabetes Care 31:369–371CrossRefPubMed
9.
go back to reference Gennuso KP, Gangnon RE, Matthews CE et al (2013) Sedentary behavior, physical activity, and markers of health in older adults. Med Sci Sports Exerc 45:1493–1500CrossRefPubMed Gennuso KP, Gangnon RE, Matthews CE et al (2013) Sedentary behavior, physical activity, and markers of health in older adults. Med Sci Sports Exerc 45:1493–1500CrossRefPubMed
10.
go back to reference Brocklebank LA, Falconer CL, Page AS et al (2015) Accelerometer-measured sedentary time and cardiometabolic biomarkers: a systematic review. Prev Med 76:92–102CrossRefPubMed Brocklebank LA, Falconer CL, Page AS et al (2015) Accelerometer-measured sedentary time and cardiometabolic biomarkers: a systematic review. Prev Med 76:92–102CrossRefPubMed
11.
go back to reference Henson J, Yates T, Biddle SJH et al (2013) Associations of objectively measured sedentary behaviour and physical activity with markers of cardiometabolic health. Diabetologia 56:1012–1020CrossRefPubMed Henson J, Yates T, Biddle SJH et al (2013) Associations of objectively measured sedentary behaviour and physical activity with markers of cardiometabolic health. Diabetologia 56:1012–1020CrossRefPubMed
12.
go back to reference Lahjibi E, Heude B, Dekker JM, et al (2013) Impact of objectively measured sedentary behaviour on changes in insulin resistance and secretion over 3 years in the RISC study: interaction with weight gain. Diabetes Metab 39:217–225 Lahjibi E, Heude B, Dekker JM, et al (2013) Impact of objectively measured sedentary behaviour on changes in insulin resistance and secretion over 3 years in the RISC study: interaction with weight gain. Diabetes Metab 39:217–225
13.
go back to reference Wijndaele K, Orrow G, Ekelund U et al (2014) Increasing objectively measured sedentary time increases clustered cardiometabolic risk: a 6 year analysis of the ProActive study. Diabetologia 57:305–312CrossRefPubMedPubMedCentral Wijndaele K, Orrow G, Ekelund U et al (2014) Increasing objectively measured sedentary time increases clustered cardiometabolic risk: a 6 year analysis of the ProActive study. Diabetologia 57:305–312CrossRefPubMedPubMedCentral
14.
go back to reference Barone Gibbs B, Pettee Gabriel K, Reis JP et al (2015) Cross-sectional and longitudinal associations between objectively measured sedentary time and metabolic disease: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Diabetes Care 38:1835–1843CrossRefPubMed Barone Gibbs B, Pettee Gabriel K, Reis JP et al (2015) Cross-sectional and longitudinal associations between objectively measured sedentary time and metabolic disease: the Coronary Artery Risk Development in Young Adults (CARDIA) study. Diabetes Care 38:1835–1843CrossRefPubMed
15.
go back to reference Bankoski A, Harris TB, McClain JJ et al (2011) Sedentary activity associated with metabolic syndrome independent of physical activity. Diabetes Care 34:497–503CrossRefPubMedPubMedCentral Bankoski A, Harris TB, McClain JJ et al (2011) Sedentary activity associated with metabolic syndrome independent of physical activity. Diabetes Care 34:497–503CrossRefPubMedPubMedCentral
16.
go back to reference Gennuso KP, Gangnon RE, Thraen-Borowski KM, Colbert LH (2014) Dose–response relationships between sedentary behaviour and the metabolic syndrome and its components. Diabetologia 58:485–492CrossRefPubMed Gennuso KP, Gangnon RE, Thraen-Borowski KM, Colbert LH (2014) Dose–response relationships between sedentary behaviour and the metabolic syndrome and its components. Diabetologia 58:485–492CrossRefPubMed
17.
go back to reference Cooper AJM, Brage S, Ekelund U et al (2014) Association between objectively assessed sedentary time and physical activity with metabolic risk factors among people with recently diagnosed type 2 diabetes. Diabetologia 57:73–82CrossRefPubMedPubMedCentral Cooper AJM, Brage S, Ekelund U et al (2014) Association between objectively assessed sedentary time and physical activity with metabolic risk factors among people with recently diagnosed type 2 diabetes. Diabetologia 57:73–82CrossRefPubMedPubMedCentral
18.
19.
go back to reference Benatti F, Ried-Larsen M (2015) The effects of breaking up prolonged sitting time. Med Sci Sports Exerc 47:2053–2061CrossRefPubMed Benatti F, Ried-Larsen M (2015) The effects of breaking up prolonged sitting time. Med Sci Sports Exerc 47:2053–2061CrossRefPubMed
20.
go back to reference Godfrey a A, Culhane KM, Lyons GM (2007) Comparison of the performance of the activPAL™ Professional physical activity logger to a discrete accelerometer-based activity monitor. Med Eng Phys 29:930–934CrossRefPubMed Godfrey a A, Culhane KM, Lyons GM (2007) Comparison of the performance of the activPAL™ Professional physical activity logger to a discrete accelerometer-based activity monitor. Med Eng Phys 29:930–934CrossRefPubMed
21.
go back to reference Kozey-Keadle S, Libertine A, Lyden K et al (2011) Validation of wearable monitors for assessing sedentary behavior. Med Sci Sports Exerc 43:1561–1567CrossRefPubMed Kozey-Keadle S, Libertine A, Lyden K et al (2011) Validation of wearable monitors for assessing sedentary behavior. Med Sci Sports Exerc 43:1561–1567CrossRefPubMed
22.
go back to reference Schram MT, Sep SJS, van der Kallen CJ et al (2014) The Maastricht Study: an extensive phenotyping study on determinants of type 2 diabetes, its complications and its comorbidities. Eur J Epidemiol 29:439–451CrossRefPubMed Schram MT, Sep SJS, van der Kallen CJ et al (2014) The Maastricht Study: an extensive phenotyping study on determinants of type 2 diabetes, its complications and its comorbidities. Eur J Epidemiol 29:439–451CrossRefPubMed
23.
go back to reference World Health Organization/International Diabetes Federation (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. World Health Organization, Geneva World Health Organization/International Diabetes Federation (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. World Health Organization, Geneva
24.
go back to reference Alberti KGMM, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645CrossRefPubMed Alberti KGMM, Eckel RH, Grundy SM et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645CrossRefPubMed
25.
26.
go back to reference Tudor-Locke C, Rowe DA (2012) Using cadence to study free-living ambulatory behaviour. Sports Med 42:381–398CrossRefPubMed Tudor-Locke C, Rowe DA (2012) Using cadence to study free-living ambulatory behaviour. Sports Med 42:381–398CrossRefPubMed
27.
go back to reference Tudor-Locke C, Barreira TV, Schuna JM et al (2015) Improving wear time compliance with a 24-hour waist-worn accelerometer protocol in the International Study of Childhood Obesity, Lifestyle and the Environment (ISCOLE). Int J Behav Nutr Phys Act 12:11CrossRefPubMedPubMedCentral Tudor-Locke C, Barreira TV, Schuna JM et al (2015) Improving wear time compliance with a 24-hour waist-worn accelerometer protocol in the International Study of Childhood Obesity, Lifestyle and the Environment (ISCOLE). Int J Behav Nutr Phys Act 12:11CrossRefPubMedPubMedCentral
28.
go back to reference Wilmot EG, Edwardson CL, Achana FA et al (2012) Sedentary time in adults and the association with diabetes, cardiovascular disease and death: systematic review and meta-analysis. Diabetologia 55:2895–2905CrossRefPubMed Wilmot EG, Edwardson CL, Achana FA et al (2012) Sedentary time in adults and the association with diabetes, cardiovascular disease and death: systematic review and meta-analysis. Diabetologia 55:2895–2905CrossRefPubMed
30.
go back to reference Hamilton M, Hamilton D, Zderic T (2007) Role of low energy expenditure and sitting in obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease. Diabetes 56:2655–2667CrossRefPubMed Hamilton M, Hamilton D, Zderic T (2007) Role of low energy expenditure and sitting in obesity, metabolic syndrome, type 2 diabetes, and cardiovascular disease. Diabetes 56:2655–2667CrossRefPubMed
31.
go back to reference Chastin SFM, Granat MH (2010) Methods for objective measure, quantification and analysis of sedentary behaviour and inactivity. Gait Posture 31:82–86CrossRefPubMed Chastin SFM, Granat MH (2010) Methods for objective measure, quantification and analysis of sedentary behaviour and inactivity. Gait Posture 31:82–86CrossRefPubMed
Metadata
Title
Associations of total amount and patterns of sedentary behaviour with type 2 diabetes and the metabolic syndrome: The Maastricht Study
Authors
Julianne D. van der Berg
Coen D. A. Stehouwer
Hans Bosma
Jeroen H. P. M. van der Velde
Paul J. B. Willems
Hans H. C. M. Savelberg
Miranda T. Schram
Simone J. S. Sep
Carla J. H. van der Kallen
Ronald M. A. Henry
Pieter C. Dagnelie
Nicolaas C. Schaper
Annemarie Koster
Publication date
01-04-2016
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 4/2016
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-015-3861-8

Other articles of this Issue 4/2016

Diabetologia 4/2016 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.